Syros pharmaceuticals merger

Author: uraz

August undefined, 2024

WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … WebApr 7, 2024 · Syros Pharmaceuticals is part of the Pharmaceuticals industry, and located in Massachusetts, United States. Syros Pharmaceuticals Location 35 Cambridge Park Dr, Cambridge, Massachusetts, 02140, United States Description Read More Industry Pharmaceuticals Healthcare Discover more about Syros Pharmaceuticals Beth Ann Work …

EX-4.2 - ir.syros.com

WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol "SYRS," and will be led by Syros’ existing management team,... WebApr 15, 2024 · Syros Pharmaceuticals has a 1-year low of $2.42 and a 1-year high of $12.93. Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) last released its quarterly earnings … crop blazer mango

Beth Ann - Executive Director,.. - Syros Pharmaceuticals ZoomInfo

WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement News Download as PDF July 05, 2024 Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance … WebKEY WINS: Steered the strategic and operational integration of Tyme Inc. into Syros Pharmaceuticals following an acquisition. Now driving business for an artificial intelligence-powered... WebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME's expected net cash at closing and … اطارات سيارات دنلوب

TYME Technologies Shares Surge On Merger Agreement With …

Syros pharmaceuticals merger

Syros Reports Second Quarter 2024 Financial Results and …

WebTyme Technologies, Inc., a biotechnology company developing cancer metabolism-based therapies, completed its acquisition by merger with Syros Pharmaceuticals, Inc., a leader … WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of …

Did you know?

WebMar 2, 2024 · Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dec 12, 2024 Syros Pharmaceuticals Announces Publication in Blood Advances … WebSep 15, 2024 · The new CUSIP number for Syros’ common stock following the reverse stock split is 87184Q206. On September 15, 2024, the holders of a majority of Syros’ …

WebJul 5, 2024 · Development stage biotech firms Syros Pharmaceuticals ( SYRS) and Tyme Technologies ( NASDAQ: TYME) announced on Tuesday that the companies entered into … WebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME’s expected net cash at closing and …

WebSep 20, 2024 · Syros Pharmaceuticals has recently acquired its peer Tyme Technologies. The sole purpose of the merger was to acquire TYME's cash balance. Concurrently with … WebSyros Pharmaceuticals, Inc., a Delaware corporation, or Syros, and Tyme Technologies, Inc., a Delaware corporation, or Tyme, entered into an Agreement and Plan of Merger, or the …

WebAug 9, 2024 · Definitive Merger Agreement with TYME Technologies and Concurrent PIPE Expected to Close 2H 2024 and Bring Combined Proceeds of Approximately $190 Million, …

WebJul 5, 2024 · Syros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME ), including its pipeline assets and net cash, after … اطارات سي ديWebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing … crop blazer blackWebSyros Pharmaceuticals, Inc. 35 CambridgePark Drive, 4th Floor . Cambridge, Massachusetts 02140 (617) 744-1340 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Nancy Simonian, M.D. President and Chief Executive Officer. crop black skinny jeansWebSep 16, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of … crop bikini topWebNov 14, 2024 · Closed Merger with TYME Technologies and Concurrent PIPE; Proceeds from Combined Transactions Augment Cash Balance, Ending Third Quarter with … اطارات سيارات اقساط اطارات سيارات نوكيانWebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement Business Wire July 5, 2024, 4:00 AM · 16 … اطارات سيرون